GHRH fragment
The first 29 amino acids retain receptor activity from native GHRH.
Back to Peptide Library
GHRH Analog
Sermorelin
GHRH(1–29) • GRF(1–29)
Sermorelin is a synthetic 29-amino-acid fragment of growth hormone–releasing hormone. It stimulates pituitary growth hormone release through the GHRH receptor and has a history of clinical use. Its community use for sleep, recovery, and body composition has less direct evidence.
At a glance
Sermorelin Quick Reference
- Community range
- 200–500mcg dailyUsually before bed while fasted
- Typical course
- 3–6 monthsReassess response and tolerability
- Class
- GHRH analog29-amino-acid active fragment
- Route
- SubQ InjectionSingle community route
Overview
What Is Sermorelin?
Sermorelin contains the first 29 amino acids of the 44-amino-acid growth hormone–releasing hormone made by the hypothalamus. That fragment retains the portion needed to activate the pituitary GHRH receptor.
Also called GHRH(1–29) or GRF(1–29), Sermorelin signals the pituitary to release endogenous growth hormone rather than supplying growth hormone directly. The resulting pulse remains subject to normal somatostatin feedback.
Growth hormone released from the pituitary acts on the liver and other tissues to increase IGF-1. That downstream signal is relevant to protein synthesis, fat metabolism, and tissue repair, but a mechanistic effect does not guarantee a visible change in a healthy adult.
Mechanism
Sermorelin Mechanism of Action
Pituitary receptor
Sermorelin binds the GHRH receptor on pituitary somatotrophs.
GH pulse
A brief signal produces endogenous growth hormone release, regulated by somatostatin feedback.
IGF-1 response
GH can increase hepatic and tissue IGF-1 signaling; outcomes vary by person and context.
Research findings
Sermorelin Benefits
Sermorelin has an established biological mechanism, while healthy-adult outcome data are less certain.
Physiological GH Release
Stimulates pituitary GH secretion while preserving normal feedback and pulsatility.
Sleep Quality
Bedtime use aligns with nocturnal GH signaling; improved sleep is a common community report.
Recovery
GH and IGF-1 signaling may support tissue repair, though individual recovery benefits are hard to isolate.
Body Composition
GHRH research in older adults reported gradual lean-mass and fat-mass changes over months.
Cognitive Research
Some small GHRH studies in older adults examined memory, attention, and executive function.
Pituitary Stimulation
Unlike injected HGH, Sermorelin stimulates rather than bypasses the pituitary.
Protocol planning
Sermorelin Dosing Protocol
No modern adult dose-finding study has established an optimal wellness or performance protocol. The member details describe community and clinic practice, not the former weight-based pediatric schedule.
Members Access Only
Sign in or create a free account to view this content.
Preparation
Sermorelin Reconstitution
Example concentration
5mg vial + 2mL bacteriostatic water
Result2.5mg/mL
Reconstitution steps
1
Prepare
Wash your hands, clean the work surface, and wipe both vial stoppers with alcohol. Allow them to dry.
2
Add diluent slowly
Use a new sterile syringe and needle to direct the selected volume of compatible diluent down the inside wall of the vial.
3
Dissolve gently
Swirl or roll the vial until the contents dissolve; do not shake.
4
Store
Store refrigerated at 2–8°C (36–46°F) and protected from light when the product instructions support this. Record the reconstitution date in your research journal.
N=1 reports
Sermorelin Community Experience
Self-reported experiences are anecdotal and do not establish treatment effects.
Positive Reports
- Deeper sleep is the most consistently reported early effect.
- Some users report less soreness and better recovery after several weeks.
- Body-composition improvements, when noticed, are usually gradual over months.
Negative & Mixed Reports
- Some report no meaningful change after months of use.
- Injection-site irritation, flushing, headache, and increased hunger are mentioned.
- Daily injections and cost can be difficult to justify for subtle results.
Stacking & synergy
Sermorelin Stacking & Synergy
These pairings are discussed in the community; track each goal separately so normal training or diet changes are not misattributed.
Sermorelin + Ipamorelin
GHRH and ghrelin-receptor pathways differ. The combination is common, but a larger acute GH pulse does not establish a better long-term outcome.
Sermorelin + GLP-1 Agonists
Changes in food intake, weight, and glucose can obscure the independent effect of Sermorelin. Monitor metabolic markers.
Sermorelin + Resistance Training
Training, sleep, and adequate protein are the practical baseline for evaluating recovery or body-composition changes.
Safety notes
Sermorelin Side Effects & Safety
Sermorelin can raise GH and IGF-1 signaling. Long-term community use calls for attention to glucose, thyroid status, swelling, joint symptoms, and other relevant health factors.
Commonly Reported Effects
- Injection-site pain, redness, or swelling.
- Brief flushing, headache, or increased hunger.
- Some users report sleep disruption or fatigue.
Other Concerns
- Water retention, tingling, or joint discomfort.
- Changes in fasting glucose or insulin sensitivity.
- Persistent headache, visual changes, or neurological symptoms need medical evaluation.
Sermorelin Precautions
Avoid or Discuss With a Clinician If
- Active cancer or an unevaluated tumor.
- Known hypersensitivity to Sermorelin or a formulation ingredient.
- An untreated intracranial lesion or pituitary mass.
- Pregnancy or breastfeeding.
Use Caution With
- Prior malignancy, diabetes, or insulin resistance.
- Untreated hypothyroidism or other pituitary disease.
- Sleep apnea, edema, carpal-tunnel symptoms, or significant joint pain.
- Concurrent glucocorticoids or direct growth hormone therapy.
Sermorelin was previously approved as Geref for pediatric GH deficiency; that product was discontinued and is not currently marketed.
Final verdict
Peptide Protocols Verdict on Sermorelin
Not medical advice. This editorial is our own opinion piece based off the experience of our own lab rats.
Our opinionated opinion
Sermorelin has old-school credibility because it was once an approved GH secretagogue. In community use, though, the results we hear about are usually modest and slow. Sleep is the most plausible early win; body-composition changes take longer and are harder to separate from training, food, and weight loss.
For most stacks, we find CJC-1295 + Ipamorelin a more compelling GH-axis option, and Tesamorelin more focused when visceral fat is the priority. Sermorelin is not a bad compound, but we would want a clear goal and measurable response before committing to months of daily injections. That practical limitation keeps it at a C.